Contrast agent-maker Guerbet (EPA:GBT) has inked a €19.5 million ($23.7m USD) deal to acquire Israeli medtech company Accurate Medical Therapeutics. Accurate has developed two series of microcatheters designed for embolization procedures of tumors and vascular aneurysms. The first set of catheters optimize the product’s ability to access hard-to-reach lesions and navigate tortuous vascular networks. The second […]